Advertisement
Advertisement
SLXN
Silexion Therapeutics Corp Ordinary Shares
1.50
USDSponsored
-0.37
-19.79%
Aug 10, 16:00 UTC -4
Closed
After-Market
1.59
+0.09
+6.00%
SLXN Earnings Reports
Positive Surprise Ratio
SLXN beat 3 of 7 last estimates.
43%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Silexion Therapeutics Corp Ordinary Shares earnings per share and revenue
On May 15, 2026, SLXN reported earnings of -8.50 USD per share (EPS) for Q1 26, beating the estimate of -13.15 USD, resulting in a 35.40% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a -5.36% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Bionano Genomics, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.69
Actual
-$0.64
Surprise
+8.40%
Biohaven Ltd.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.74
Actual
-$0.91
Surprise
-21.67%
Alamar Biosciences, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.33
Actual
-$0.22
Surprise
+33.83%
Olema Pharmaceuticals, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.55
Actual
-$0.61
Surprise
-9.83%
Enanta Pharmaceuticals, Inc
Report Date
Aug 10, 2026 For Q3 26
Estimate
-$0.52
Actual
-$0.67
Surprise
-28.80%
Rocket Pharmaceuticals, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.24
Actual
-$0.15
Surprise
-160.80%
Palisade Bio, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.05
Actual
-$0.05
Surprise
+6.19%
DiaMedica Therapeutics Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.20
Actual
-$0.19
Surprise
+6.86%
Orchestra BioMed Holdings, Inc. Ordinary Shares
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.39
Actual
-$0.38
Surprise
+4.95%
Nkarta, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.54
Surprise
-40.81%
FAQ
What were Silexion Therapeutics Corp Ordinary Shares's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Silexion Therapeutics Corp Ordinary Shares reported EPS of -$8.50, beating estimates by 35.4%, and revenue of --, -- -- expectations.
How did the market react to Silexion Therapeutics Corp Ordinary Shares's Q1 2026 earnings?
The stock price moved down -5.36%, changed from $0.29 before the earnings release to $0.27 the day after.
When is Silexion Therapeutics Corp Ordinary Shares expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Silexion Therapeutics Corp Ordinary Shares's next earnings report?
Based on --
analysts, Silexion Therapeutics Corp Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement